WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'9201 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 2'2591 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 1'185  1'157  1'129  1'102  1'078  847  740  578 
Births 44  44  44  43  43  37  33  23 
Surviving infants 42  42  42  41  41  35  28  18 
Pop. less than 5 years 204  194  179  164  154  174  123  73 
Pop. less than 15 years 502  489  473  456  443  424  292  225 
Female 15-49 years 262  257  252  248  244  168  191  151 

Number of reported cases

(Click for retrospective incidence data for Timor-Leste)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  43  47  16  763 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  11  10 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Timor-Leste)
Vaccine year result method % card seen                                                
BCG 2008  77  DHS   50  90  79  82  71  68 
DTP1 2008  75  DHS   50  90  81  86  82  69 
DTP3 2008  66  DHS   50  90  77  82  83  67 
DTP4         
IPV1         
HepB_BD         
HepB3 2008  66  DHS   50  90  77  82  83  67 
Hib3          90  77  82 
JapEnc         
MCV1          95  74  70  73  62 
MCV2         
PCV1         
PCV3         
Pol3 2008  56  DHS   50  90  76  82  83  66 
Rota1         
RotaC         
RCV1         
TT2plus 2004  60  EPI   26  80  37  37  39  38 
PAB         
VAD1          90  61  58  57  39 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Timor-Leste)
BCG
ChartChart
  79  79  82  71  68 
DTP1
ChartChart
  80  81  86  94  69 
DTP3
ChartChart
  76  77  82  83  67 
HepB3
ChartChart
  76  77  82  83  67 
HepB_BD
ChartChart
 
Hib3
ChartChart
  76  77  82 
IPV1
ChartChart
 
MCV1
ChartChart
  70  74  70  73  62 
MCV2
ChartChart
 
PAB
ChartChart
  81  81  81  81  81 
PCV3
ChartChart
 
Pol3
ChartChart
  75  76  82  83  66 
RCV1
ChartChart
 
RotaC
ChartChart
 

Number of districts in the country 13  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 15
From 80 to 89% 23
From 50 to 79% 62
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes <1 year
DT +5 years; Yes From February 2016
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes From February 2016
MR 9, 18 months; Yes From February 2016
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +4, +6 months; +1, +1 year; Yes pregnant mothers
VitaminA 6, 12, 18, 24 months; above 2 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2020  2013-2015  2009-2013  2009-2013  2009-2013    2009-2013 
Nº of districts with microplans that include activities to raise immunization coverage number 13  13  13  10  13 

System performance

Total Nº districts in country number 13  13  13  13  13  13  13 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 38  46  62  54  15  23  46 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 15  15  15 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 53  39  18  19  30  60 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No  No  No   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.